3D Bioprinting Market of Living Human Tissues/Organs - Industry Analysis, size, Share and Upcoming Trends (2021-2027)

Research report presented by UnivDatos, Emphasis on Application (Research and Clinical), Technology (Inkjet, Extrusion, Laser-Assisted Bioprinting, and others), Material (Collagen, Gelatin, Alginate, Synthetic Macromolecules, Hyaluronic Acid, Generic Hydroge, and Others), Tissue Type (Generic Tissue/Organ, Renal, Skin, Bone, Liver, Lungs, Cardiac / Cardiovascular, Adipose Tissue, Cartilage, Ocular Tissue, Tumor Tissue, and Others) and Geographical analysis (key regions and country).

As per the research report, Global 3D Bioprinting of Living Human Tissues/Organs Market is expected to reach the market valuation of US$ 2,846.3 million by 2027 expanding at a reasonable CAGR of 20.75% during the forecast period (2021-2027) from US$ 651.6 million in 2019. 3D Bioprinting of Live Human Tissues/Organs is an additive manufacturing process that prints tissue or living structures layer by layer, mimicking the actions of normal living systems, using cells and other biocompatible materials such as bio inks.

In the fields of tissue engineering and regenerative medicine, 3D bioprinting has emerged as a promising modern method for fabricating complex biological structures. It aims to overcome the drawbacks of traditional tissue engineering approaches by layering biomaterials in a desired 3D pattern in a detailed and regulated manner, according to government data on organ procurement and transplantation in the United States, 17 people die each year while waiting for an organ transplant.

For complete research, request for Sample of the report browse through – https://univdatos.com/request_form/form/361

Furthermore, according to the American Society of Transplantation, anyone is added to the national transplant waiting list in the United States every ten minutes. Every day, about 20-25 people die while awaiting transplant surgery. In addition, the industry's limited number of organ donors would necessitate 3D bioprinting of live human tissue in the coming years According to a poll conducted by Organ Donor.Gov, 90 percent of people in the United States favour organ donation, but just 60 percent have signed up as donors. Just 3 out of 1,000 people die in such a manner that organ donation is possible, despite the fact that one person will donate up to 8 lifesaving organs.

Furthermore, the market for organ transplantation is rising in Europe, but there aren't enough organs to satisfy the demand. The scarcity of organs has been a limiting factor in the treatment of multiple patients with chronic organ loss, resulting in long waiting lists, according to the Council of Europe, over 150,000 people in Europe were on organ waiting lists in 2020. Furthermore, 41,000 patients undergo transplants on average each year, and 48,000 additional patients are added to waiting lists. Per hour, almost six new patients are admitted to the transplant waiting list.

For a detailed analysis of the applications in the Smart Home Market browse through – https://univdatos.com/report/global-3d-bioprinting-of-living-human-tissues-organs-market-current-analysis-and-forecast

Insights Presented in the Report

“Amongst technology, extrusion segment dominated the market during the forecast period”

The market is divided into four categories based on technology: inkjet, extrusion, laser-assisted bioprinting, and others. The extrusion segment has the highest industry sales share of 57.2 percent in 2019 and is predicted to remain dominant over the forecast period.

“Amongst application, Clinical segment holds the major share”

The market is divided into two categories based on the vector type: research and clinical. Because of the growing demand for organ transplantation such as bone, skin, and heart valves, the clinical segment dominated the market in 2019 with a share of 75.1 percent and is projected to continue to do so throughout the forecast period.

Browse - Nanotechnology in Drug Delivery Market: Research Report Overview by Industry Size, Share, Trends, Growth & Leading Players (2021-2027)

“Amongst tissue type, Generic Tissue/Organ segment holds the major share”

The market is divided into Generic Tissue/Organ, Renal, Skin, Bone, Liver, Lungs, Cardiac/Cardiovascular, Adipose Tissue, Cartilage, Ocular Tissue, Tumor Tissue, and Other Tissue Types based on tissue type. In 2019, With 36.7 percent market share in 2019, the Generic Tissue/Organ segment is projected to be the leading segment of the 3D Bioprinting Market of Living Human Tissues/Organs during the forecast period due to an increase in the number of patients seeking organ transplants. According to a survey, a new patient is added to the waiting list every ten minutes, with about 4,000 patients waiting for a transplant in the United States each year.

“Amongst material, Collagen segment dominated the market during the forecast period”

The market is divided into Collagen, Gelatin, Alginate, Synthetic Macromolecules, Hyaluronic Acid, Generic Hydroge, and others based on the content. Due to the increased usage of collagen biomaterial in various regenerative medicine and disease modelling applications, the collagen category accounted for a maximum market sales share of 16.2 percent in 2019 and is anticipated to remain dominant throughout the studied span (e.g., skin, bone, and cornea).

“North America represents one of the largest markets of 3D Bioprinting of Living Human Tissues/Organs market”

A systematic research was performed for various regions around the globe, including North America (the United States, Canada, and the Rest of North America), Europe (Germany, France, Spain, the United Kingdom, and the Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and the Rest of the World to gain a greater understanding of the business conditions of the 3D Bioprinting of Living Human Tissues/Organs market. Because of the rising prevalence of chronic diseases and increased support for R&D activities associated with 3D Bioprinting of Living Human Tissues/Organs, North America led the industry in 2019, generating sales of US$ 235.4 million.

The 3D Bioprinting Market of Living Human Tissues/Organs can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.